These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28073317)

  • 1. Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.
    Wu Z; Li L; Xie F; Du J; Zuo Y; Frost JA; Carlton SM; Walters ET; Yang Q
    J Neurotrauma; 2017 Mar; 34(6):1260-1270. PubMed ID: 28073317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury.
    Wu Z; Li L; Xie F; Xu G; Dang D; Yang Q
    J Pharmacol Exp Ther; 2020 Apr; 373(1):72-80. PubMed ID: 31969383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain.
    Cai J; Fang D; Liu XD; Li S; Ren J; Xing GG
    Oncol Rep; 2015 Mar; 33(3):1540-50. PubMed ID: 25592230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNQ2/3/5 channels in dorsal root ganglion neurons can be therapeutic targets of neuropathic pain in diabetic rats.
    Yu T; Li L; Liu H; Li H; Liu Z; Li Z
    Mol Pain; 2018; 14():1744806918793229. PubMed ID: 30027794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.
    Abd-Elsayed AA; Ikeda R; Jia Z; Ling J; Zuo X; Li M; Gu JG
    Mol Pain; 2015 Jul; 11():45. PubMed ID: 26227020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats.
    Xu W; Wu Y; Bi Y; Tan L; Gan Y; Wang K
    Mol Pain; 2010 Aug; 6():49. PubMed ID: 20796319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
    Li L; Li J; Zuo Y; Dang D; Frost JA; Yang Q
    J Pain; 2019 May; 20(5):528-539. PubMed ID: 30471428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
    Hansen HH; Weikop P; Mikkelsen MD; Rode F; Mikkelsen JD
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):46-51. PubMed ID: 27377794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model.
    Zheng Q; Fang D; Liu M; Cai J; Wan Y; Han JS; Xing GG
    Pain; 2013 Mar; 154(3):434-448. PubMed ID: 23352759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin Dysregulation Underlies Spinal Cord Injury-Induced K
    Zemel BM; Muqeem T; Brown EV; Goulão M; Urban MW; Tymanskyj SR; Lepore AC; Covarrubias M
    J Neurosci; 2017 Aug; 37(34):8256-8272. PubMed ID: 28751455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of A-fiber-mediated excitatory transmission underlies the analgesic effects of KCNQ channel opening in the spinal dorsal horn.
    Oyama M; Watanabe S; Iwai T; Tanabe M
    Neuropharmacology; 2024 Aug; 254():109994. PubMed ID: 38750803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.
    Hansen HH; Ebbesen C; Mathiesen C; Weikop P; Rønn LC; Waroux O; Scuvée-Moreau J; Seutin V; Mikkelsen JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1006-19. PubMed ID: 16775195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.
    Hansen HH; Andreasen JT; Weikop P; Mirza N; Scheel-Krüger J; Mikkelsen JD
    Eur J Pharmacol; 2007 Sep; 570(1-3):77-88. PubMed ID: 17628530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of KVO treatment strategies for chronic pain in a rat model of Gulf War Illness.
    Flunker LK; Nutter TJ; Bowers CM; Cooper BY
    Toxicol Appl Pharmacol; 2022 Jan; 434():115821. PubMed ID: 34896435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips.
    Zagorchev P; Apostolova E; Kokova V; Peychev L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):439-46. PubMed ID: 26815201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission.
    Sotty F; Damgaard T; Montezinho LP; Mørk A; Olsen CK; Bundgaard C; Husum H
    J Pharmacol Exp Ther; 2009 Mar; 328(3):951-62. PubMed ID: 19098162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres.
    Roza C; Lopez-Garcia JA
    Pain; 2008 Sep; 138(3):537-545. PubMed ID: 18331780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNQ/M currents in sensory neurons: significance for pain therapy.
    Passmore GM; Selyanko AA; Mistry M; Al-Qatari M; Marsh SJ; Matthews EA; Dickenson AH; Brown TA; Burbidge SA; Main M; Brown DA
    J Neurosci; 2003 Aug; 23(18):7227-36. PubMed ID: 12904483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peripheral KCNQ channels attenuates inflammatory pain.
    Hayashi H; Iwata M; Tsuchimori N; Matsumoto T
    Mol Pain; 2014 Feb; 10():15. PubMed ID: 24555569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Kv3.4 channels in dorsal root ganglia following spinal cord injury.
    Ritter DM; Zemel BM; Hala TJ; O'Leary ME; Lepore AC; Covarrubias M
    J Neurosci; 2015 Jan; 35(3):1260-73. PubMed ID: 25609640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.